Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 2163-2171

  Huang, Z ^a   Dry, I ^b   Webster, D ^b   Strugnell, R ^c   Wesselingh, S ^a  

^a MONASH UNIVERSITY   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Measles; Neutralizing antibodies; Oral; Plant derived vaccine; Virus hemagglutinin protein

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES VACCINE; NEUTRALIZING ANTIBODY; PLANT EXTRACT; PLANT RNA; RECOMBINANT PROTEIN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; IN VITRO STUDY; MEASLES VACCINATION; MEASLES VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT LEAF; PRIORITY JOURNAL; TOBACCO; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; FEMALE; GENETIC VECTORS; HEMAGGLUTININS, VIRAL; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; MEASLES VACCINE; MEASLES VIRUS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PLANTS, GENETICALLY MODIFIED; PLANTS, TOXIC; PLASMIDS; RECOMBINANT PROTEINS; TOBACCO;

EID: 0035961537     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00390-X     Document Type: Article

References (41)

1. Vaccine-preventable childhood diseases in Australia
2. Duration of live measles vaccine-induced immunity
3. Measles outbreaks in the United States, 1987 through 1990
4. Concerns about immunization
5. Geographical variation in infant loss of maternal measles antibody and in prevalence of rubella antibody
6. Loss of maternal measles antibody in black South African infants in the first year of life - Implications for age of vaccination
7. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines
8. Child mortality after high-titre measles vaccines: Prospective study in Senegal
9. Measles battle loses potent weapon
10. Plant-based production of xenogenic proteins
11. Oral immunization with a recombinant bacterial antigen produced in transgenic plants
12. Immunogenicity of transgenic plant-derived hepatitis B surface antigen
13. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
14. Efficacy of a food plant-based oral cholera toxin B subunit vaccine
15. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants
16. Immunization against rabies with plant-derived antigen
17. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
18. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immuniztion with alfalfa transgenic plants expressing the viral structural protein VP1
19. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1
20. Nuclear transport of plant potyviral proteins
21. A C-terminal signal prevents secretion of luminal ER proteins
22. Developmentally regulated cell death on expression of the fungal avirulence gene Avr9 in tomato seedlings carrying the disease-resistance gene Cf-9
23. Binary Agrobacterium vectors for plant transformation
24. A simple and general method for transferring genes into plants
25. Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants
26. Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus hemagglutinin protein
27. Analysis of the N-glycosylation of recombinant glycoproteins produced in transgenic plants
28. Measles vaccines: Novel generations and new strategies
29. Edible vaccine protects mice against Escherichia coli heat-labile entertoxin (LT): Potatoes expressing a synthetic LT-B gene
30. A plant-derived edible vaccine against hepatitis B virus
31. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice
32. The mucosal immune system: From fundamental concepts to vaccine development
33. Food plant-synthesized cholera toxin B subunit as an immunogen and antigen delivery systems
34. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes
35. Correlation between epitopes on hemagglutinin of measles virus and biological activities: Passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity
36. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein
37. Contribution of measles virus fusion protein in protective immunity: Anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge
38. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice
39. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies